Post by IndiaMedToday

Immuneel and Arogya Finance launch India’s first zero-cost EMI programme of up to ₹25 lakh to improve patient access to Qartemi CAR-T cancer therapy. Amit Mookim Immuneel Therapeutics Pvt. Ltd. Jose Peter #IndiaMedToday #HappiestHealth #DigitalHealthcare #HealthcareInnovation #AIHealthcare #VirtualCare #HealthcareLeadership #HealthTech #DigitalTransformation #HealthcareNews